Clarifying the signaling pathways induced or inhibited by Gal-9 in different cell-population, during HIV infection, may provide insights that may lead to the development of novel therapies to improve immune functionality, and reduce inflammation-associated co-morbidities, in the setting of viral suppression by ART. The gene discussed is LGALS9; the disease is HIV infectious disease.